Literature DB >> 23579411

Vitreomacular traction syndrome: the role of intravitreal plasmin injection is still not clear.

A Grzybowski, F J Ascaso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23579411      PMCID： PMC3682366          DOI： 10.1038/eye.2013.61

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.

Authors:  Amal M Elbendary; Mohamed M Elwan; Hanan A Azzam; Doaa R Eldeeb
Journal:  Curr Eye Res       Date:  2011-06       Impact factor: 2.424

2.  Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment.

Authors:  M Codenotti; G Maestranzi; U De Benedetto; G Querques; P Della Valle; L Iuliano; G Fogliato; A D'Angelo; F Bandello
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

3.  Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial).

Authors:  Peter Stalmans; Christophe Delaey; Marc D de Smet; Edith van Dijkman; Steve Pakola
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

4.  [Enzymatic vitrectomy by intravitreal autologous plasmin injection as initial treatment for macular epiretinal membranes and vitreomacular traction syndrome].

Authors:  M Díaz-Llopis; P Udaondo; E Cervera; S García-Delpech; D Salom; A Quijada; F J Romero
Journal:  Arch Soc Esp Oftalmol       Date:  2009-02
  4 in total
  1 in total

1.  Reply to Grzybowski and Ascaso.

Authors:  G Querques; M Codenotti; G Maestranzi; L Iuliano; F Bandello
Journal:  Eye (Lond)       Date:  2013-04-12       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.